CJC-1134-PC

· Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CJC-1134-PC, covering 2017-06-02 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues [Phase 3]

See pricing